Development of Pelubiprofen Tromethamine with Improved Gastrointestinal Safety and Absorption
Pelubiprofen (PEL), which is a commercialized non-steroidal anti-inflammatory drug (NSAID), is associated with the risk of gastrointestinal (GI) adverse events following long-term exposure and has poor water-soluble properties. Here, a new pelubiprofen tromethamine (PEL-T) with improved solubility,...
Main Authors: | Ji Yeon Park, Dong Ho Oh, Sang-Wook Park, Bo Ram Chae, Chul Woo Kim, Sang Heon Han, Hyeon Jong Shin, Soo Bin Yeom, Da Yeong Lee, Min Kyu Park, Sang-Eun Park, Jun-Bom Park, Kyung-Tae Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/5/745 |
Similar Items
-
Sustained-release solid dispersion of pelubiprofen using the blended mixture of aminoclay and pH independent polymers: preparation and in vitro/in vivo characterization
by: Yeo-Song Lee, et al.
Published: (2017-01-01) -
Studies on Surfactants, Cosurfactants, and Oils for Prospective Use in Formulation of Ketorolac Tromethamine Ophthalmic Nanoemulsions
by: Shahla S. Smail, et al.
Published: (2021-03-01) -
Refractory bradycardia – a rare complication of carboprost tromethamine for induction of abortion
by: Jasna Čerkez Habek, et al.
Published: (2016-01-01) -
Development and validation of Ketorolac Tromethamine in eye drop formulation by RP-HPLC method
by: G. Sunil, et al.
Published: (2017-02-01) -
A Swine Model for the Quantification of Pelvic Adhesions and the Encapsulation of Ketorolac Tromethamine for the Prevention of Adhesion Formation
by: Cheung, Maureen Elizabeth
Published: (2010)